Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial.

Basilico N, Parapini S, Sparatore A, Romeo S, Misiano P, Vivas L, Yardley V, Croft SL, Habluetzel A, Lucantoni L, Renia L, Russell B, Suwanarusk R, Nosten F, Dondio G, Bigogno C, Jabes D, Taramelli D.

Molecules. 2017 Dec 1;22(12). pii: E2102. doi: 10.3390/molecules22122102.

2.

Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells.

Brunati C, Thomsen TT, Gaspari E, Maffioli S, Sosio M, Jabes D, Løbner-Olesen A, Donadio S.

J Antimicrob Chemother. 2018 Feb 1;73(2):414-424. doi: 10.1093/jac/dkx395.

3.

Dugong: a Docker image, based on Ubuntu Linux, focused on reproducibility and replicability for bioinformatics analyses.

Menegidio FB, Jabes DL, Costa de Oliveira R, Nunes LR.

Bioinformatics. 2018 Feb 1;34(3):514-515. doi: 10.1093/bioinformatics/btx554.

PMID:
28968637
4.

Functional and Evolutionary Characterization of a UDP-Xylose Synthase Gene from the Plant Pathogen Xylella fastidiosa, Involved in the Synthesis of Bacterial Lipopolysaccharide.

Alencar VC, Jabes DL, Menegidio FB, Sassaki GL, de Souza LR, Puzer L, Meneghetti MC, Lima MA, Tersariol IL, de Oliveira RC, Nunes LR.

Biochemistry. 2017 Feb 7;56(5):779-792. doi: 10.1021/acs.biochem.6b00886. Epub 2017 Jan 26.

PMID:
28125217
5.

Thioridazine inhibits gene expression control of the cell wall signaling pathway (CWI) in the human pathogenic fungus Paracoccidioides brasiliensis.

Jabes DL, de Freitas Oliveira AC, Alencar VC, Menegidio FB, Reno DL, Santos DS, Barbosa DA, Vilas Boas RO, de Oliveira Rodrigues Cunha RL, Rodrigues T, Costa de Oliveira R, Nunes LR.

Mol Genet Genomics. 2016 Jun;291(3):1347-62. doi: 10.1007/s00438-016-1184-1. Epub 2016 Mar 8.

PMID:
26956010
6.

Erratum for Jabes et al., Pharmacological Properties of NAI-603, a Well-Tolerated Semisynthetic Derivative of Ramoplanin.

Jabes D, Brunati C, Candiani G, Riva S, Romanó G, Maffioli S, Rossi R, Simone M, Gaspari E, Donadio S.

Antimicrob Agents Chemother. 2015 Oct;59(10):6675. doi: 10.1128/AAC.01526-15. No abstract available.

7.

A Derivative of the Thiopeptide GE2270A Highly Selective against Propionibacterium acnes.

Fabbretti A, He CG, Gaspari E, Maffioli S, Brandi L, Spurio R, Sosio M, Jabes D, Donadio S.

Antimicrob Agents Chemother. 2015 Aug;59(8):4560-8. doi: 10.1128/AAC.05155-14. Epub 2015 May 18.

8.

Characterization of HIV-1 entry inhibitors with broad activity against R5 and X4 viral strains.

Sironi F, Malnati M, Mongelli N, Cozzi P, Guzzo C, Ghezzi S, Martínez-Romero C, García-Sastre A, Lusso P, Jabes D, Biswas P.

J Transl Med. 2015 Apr 2;13:107. doi: 10.1186/s12967-015-0461-9.

9.

Pharmacological properties of NAI-603, a well-tolerated semisynthetic derivative of ramoplanin.

Jabes D, Brunati C, Candiani G, Riva S, Romanó G, Maffioli S, Rossi R, Simone M, Gaspari E, Donadio S.

Antimicrob Agents Chemother. 2014;58(4):1922-9. doi: 10.1128/AAC.01620-13. Epub 2014 Jan 13. Erratum in: Antimicrob Agents Chemother. 2015 Oct;59(10):6675.

10.

The antibiotic R&D pipeline: an update.

Jabes D.

Curr Opin Microbiol. 2011 Oct;14(5):564-9. doi: 10.1016/j.mib.2011.08.002. Epub 2011 Aug 26. Review.

PMID:
21873107
11.

Efficacy of the new lantibiotic NAI-107 in experimental infections induced by multidrug-resistant Gram-positive pathogens.

Jabés D, Brunati C, Candiani G, Riva S, Romanó G, Donadio S.

Antimicrob Agents Chemother. 2011 Apr;55(4):1671-6. doi: 10.1128/AAC.01288-10. Epub 2011 Jan 10.

12.

Synthesis and anti-mycobacterial activities of triazoloquinolones.

Carta A, Palomba M, Briguglio I, Corona P, Piras S, Jabes D, Guglierame P, Molicotti P, Zanetti S.

Eur J Med Chem. 2011 Jan;46(1):320-6. doi: 10.1016/j.ejmech.2010.11.020. Epub 2010 Nov 19.

PMID:
21145625
13.

Sources of novel antibiotics--aside the common roads.

Donadio S, Maffioli S, Monciardini P, Sosio M, Jabes D.

Appl Microbiol Biotechnol. 2010 Dec;88(6):1261-7. doi: 10.1007/s00253-010-2877-8. Epub 2010 Sep 24. Review.

PMID:
20865256
14.

Antibiotic discovery in the twenty-first century: current trends and future perspectives.

Donadio S, Maffioli S, Monciardini P, Sosio M, Jabes D.

J Antibiot (Tokyo). 2010 Aug;63(8):423-30. doi: 10.1038/ja.2010.62. Epub 2010 Jun 16. Review.

PMID:
20551985
15.

Strategies for the isolation and characterization of antibacterial lantibiotics.

Jabes D, Donadio S.

Methods Mol Biol. 2010;618:31-45. doi: 10.1007/978-1-60761-594-1_3.

PMID:
20094856
16.

Synthesis and preliminary biological characterization of new semisynthetic derivatives of ramoplanin.

Ciabatti R, Maffioli SI, Panzone G, Canavesi A, Michelucci E, Tiseni PS, Marzorati E, Checchia A, Giannone M, Jabes D, Romano G, Brunati C, Candiani G, Castiglione F.

J Med Chem. 2007 Jun 28;50(13):3077-85. Epub 2007 Jun 2.

PMID:
17542573
17.

Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection.

Freeman J, Baines SD, Jabes D, Wilcox MH.

J Antimicrob Chemother. 2005 Oct;56(4):717-25. Epub 2005 Sep 5.

PMID:
16143709
18.

Human pharmacokinetics and rationale for once-weekly dosing of dalbavancin, a semi-synthetic glycopeptide.

Dorr MB, Jabes D, Cavaleri M, Dowell J, Mosconi G, Malabarba A, White RJ, Henkel TJ.

J Antimicrob Chemother. 2005 Mar;55 Suppl 2:ii25-30. Review.

PMID:
15750034
19.

In vitro antistaphylococcal activity of dalbavancin, a novel glycopeptide.

Lopez S, Hackbarth C, Romanò G, Trias J, Jabes D, Goldstein BP.

J Antimicrob Chemother. 2005 Mar;55 Suppl 2:ii21-4.

PMID:
15750033
20.

Supplemental Content

Loading ...
Support Center